Thyroid cancer is one of the fastest growing incidences of cancer in the nation. It’s also one of the most commonly treated cancers at the Methodist Head and Neck Surgical Oncology Clinic.
Thyroid cancer affects nearly 54,000 Americans each year. While there are many different varieties of thyroid cancer, most thyroid cancers can be treated successfully.
It's the second leading cause of cancer death in the U.S., yet a third of the people most at risk have never been tested. What you need to know about colon cancer screening.
May is Skin Cancer Awareness Month. What should you watch for when it comes to protecting your skin? (VIDEO)
When we hear the word cancer, most people tend to think of older people being more at risk. But when it comes to testicular cancer, younger men are the ones in the danger zone.
Do you ever wonder how doctors determine what cancer treatments are the most effective? Or the risk factors for a cancer? It all starts with a Cancer Registry. Learn how the registrar helps improve prevention and treatment by analyzing cancer data.
Are you at risk for oral, head or neck cancer? This Thursday, April 5, we are hosting a free cancer screening at Methodist Estabrook Cancer Center from 3 to 6pm. Screening appointments are available, register in advance at (402) 354-5850.
Read more about the symptoms, risk factors and screening for oral, head and neck cancers.
During cancer treatment, the so-called rules of nutrition convention typically fly out the window. For patients struggling to maintain weight, a high-protein, high-calorie diet may be just what the doctor ordered. Nutrition services at Methodist Estabrook Cancer Center are for anyone with a cancer diagnosis, no matter where they seek their treatment, and it’s all free of charge as part of Harper’s Hope.
More than 130 models took center stage at the Methodist Cancer Survivor Style Show on March 1. Beneath the gorgeous hair, makeup and clothes was a courageous survivor spirit much more beautiful than anything the audience could see from the outside.